Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
19.15
-0.45 (-2.30%)
Dec 3, 2024, 1:35 PM EST - Market open
Avanos Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 15.7 | -61.8 | 50.5 | 6.3 | -29 | -45.9 | Upgrade
|
| Depreciation & Amortization | 48.5 | 46.1 | 47.7 | 38.3 | 42.9 | 36.9 | Upgrade
|
| Loss (Gain) From Sale of Assets | 72 | 72.7 | 1.1 | 8 | 23.7 | 0.6 | Upgrade
|
| Asset Writedown & Restructuring Costs | -59.1 | - | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 14 | 15.8 | 15.9 | 13.2 | 12.1 | 10.5 | Upgrade
|
| Other Operating Activities | -17.1 | -22.4 | - | -3 | 13.2 | -17 | Upgrade
|
| Change in Accounts Receivable | 2.1 | 39 | -24.7 | -10.8 | 45.8 | -0.8 | Upgrade
|
| Change in Inventory | 5.4 | 4.7 | -30.9 | 15.7 | -19.4 | -21.3 | Upgrade
|
| Change in Accounts Payable | 0.4 | -14.4 | 35.4 | -11.9 | -18.9 | -83.6 | Upgrade
|
| Change in Other Net Operating Assets | -23.8 | -47.3 | -4.1 | 31.5 | -72.9 | 46.1 | Upgrade
|
| Operating Cash Flow | 55.5 | 32.4 | 90.9 | 87.3 | -2.5 | -74.5 | Upgrade
|
| Operating Cash Flow Growth | 3.93% | -64.36% | 4.12% | - | - | - | Upgrade
|
| Capital Expenditures | -18.9 | -17.8 | -19.3 | -21 | -20.2 | -50.6 | Upgrade
|
| Cash Acquisitions | -2.1 | -49.6 | -116.1 | - | -4 | -57.5 | Upgrade
|
| Divestitures | 91.1 | 89 | - | - | - | - | Upgrade
|
| Investing Cash Flow | 61.1 | 21.6 | -135.4 | -21 | -24.2 | -108.1 | Upgrade
|
| Long-Term Debt Issued | - | 55 | 400 | 20 | 185 | - | Upgrade
|
| Total Debt Issued | 20 | 55 | 400 | 20 | 185 | - | Upgrade
|
| Long-Term Debt Repaid | - | -119.7 | -296.6 | -70 | -254.8 | -0.2 | Upgrade
|
| Total Debt Repaid | -122.9 | -119.7 | -296.6 | -70 | -254.8 | -0.2 | Upgrade
|
| Net Debt Issued (Repaid) | -102.9 | -64.7 | 103.4 | -50 | -69.8 | -0.2 | Upgrade
|
| Issuance of Common Stock | 0.9 | 1.3 | 1.7 | 6.2 | 3.4 | 5.3 | Upgrade
|
| Repurchase of Common Stock | -18.9 | -19.1 | -45.5 | -11.5 | -0.9 | -3.6 | Upgrade
|
| Other Financing Activities | -15.5 | -11.7 | -2.9 | - | -2.7 | - | Upgrade
|
| Financing Cash Flow | -136.4 | -94.2 | 56.7 | -55.3 | -70 | 1.5 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.7 | 0.2 | -3 | -4 | 2.9 | 1.9 | Upgrade
|
| Net Cash Flow | -18.1 | -40 | 9.2 | 7 | -93.8 | -179.2 | Upgrade
|
| Free Cash Flow | 36.6 | 14.6 | 71.6 | 66.3 | -22.7 | -125.1 | Upgrade
|
| Free Cash Flow Growth | 0% | -79.61% | 7.99% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 5.37% | 2.17% | 10.47% | 11.29% | -3.18% | -17.93% | Upgrade
|
| Free Cash Flow Per Share | 0.79 | 0.31 | 1.51 | 1.36 | -0.47 | -2.63 | Upgrade
|
| Cash Interest Paid | 14.7 | 14.7 | 8.1 | 3 | 16.8 | 16.7 | Upgrade
|
| Cash Income Tax Paid | 23.6 | 23.6 | -2.9 | -45 | - | 8.4 | Upgrade
|
| Levered Free Cash Flow | 142.75 | 200.79 | -74.26 | 51.3 | -41.7 | -87.49 | Upgrade
|
| Unlevered Free Cash Flow | 150.69 | 210.16 | -68.01 | 53.36 | -31.95 | -78.11 | Upgrade
|
| Change in Net Working Capital | -71.9 | -137.5 | 139 | -20.3 | 69.5 | 70.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.